Use of Erythropoietin to Expand Regulatory T Cells in Autoimmune Liver Disease

NCT03842254 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Hepatitis

Interventions

DRUG: Erythropoietin

Sponsor

Northwestern University

Collaborators

[object Object]
[object Object]